Cosmos Pharmaceutical Corp
TSE:3349
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5 827.5
8 520.0622
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 7 020.26 JPY. Compared to the current market price of 7 149 JPY, Cosmos Pharmaceutical Corp is Overvalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cosmos Pharmaceutical Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Cosmos Pharmaceutical Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cosmos Pharmaceutical Corp
Balance Sheet Decomposition
Cosmos Pharmaceutical Corp
Current Assets | 156.4B |
Cash & Short-Term Investments | 51.4B |
Receivables | 658m |
Other Current Assets | 104.3B |
Non-Current Assets | 328.6B |
PP&E | 302.2B |
Intangibles | 474m |
Other Non-Current Assets | 25.9B |
Current Liabilities | 216.8B |
Accounts Payable | 181.7B |
Other Current Liabilities | 35.2B |
Non-Current Liabilities | 31B |
Long-Term Debt | 22.3B |
Other Non-Current Liabilities | 8.7B |
Earnings Waterfall
Cosmos Pharmaceutical Corp
Revenue
|
985.2B
JPY
|
Cost of Revenue
|
-789.3B
JPY
|
Gross Profit
|
195.9B
JPY
|
Operating Expenses
|
-161.8B
JPY
|
Operating Income
|
34.1B
JPY
|
Other Expenses
|
-8B
JPY
|
Net Income
|
26.1B
JPY
|
Free Cash Flow Analysis
Cosmos Pharmaceutical Corp
JPY | |
Free Cash Flow | JPY |
Profitability Score
Profitability Due Diligence
Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Cosmos Pharmaceutical Corp's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Cosmos Pharmaceutical Corp's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 8 593.11 JPY with a low forecast of 6 716.5 JPY and a high forecast of 10 500 JPY.
Dividends
Current shareholder yield for Cosmos Pharmaceutical Corp is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. The company is headquartered in Fukuoka, Fukuoka-Ken and currently employs 4,872 full-time employees. The company went IPO on 2004-11-11. The firm offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. The company also provides tobacco and others.
Contact
IPO
Employees
Officers
The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 7 020.26 JPY.
Compared to the current market price of 7 149 JPY, Cosmos Pharmaceutical Corp is Overvalued by 2%.